Steven A Johnson

Title: Innovations in Schizophrenia Treatment by Steven A Johnson

Introduction

Steven A Johnson is an accomplished inventor based in Costa Mesa, CA (US). He has made significant contributions to the field of psychiatry, particularly in the treatment of schizophrenia. His innovative approach combines the use of ampakines and neuroleptics to enhance treatment outcomes for individuals suffering from this complex disorder.

Latest Patents

Johnson holds a patent for the "Treatment of schizophrenia with ampakines and neuroleptics." This invention focuses on improving receptor functioning in brain networks that are responsible for higher-order behaviors. Specifically, it details methods for using AMPA receptor up-modulators alongside antipsychotics to treat schizophrenia. Additionally, the patent includes kits containing the necessary compositions for effective administration. He has 1 patent to his name.

Career Highlights

Throughout his career, Johnson has worked with notable organizations, including Cortex Pharmaceuticals, Inc. and the University of California. His work has been pivotal in advancing the understanding and treatment of schizophrenia, showcasing his dedication to improving mental health care.

Collaborations

Some of his notable coworkers include Gary S Lynch and Gary A Rogers, who have contributed to the research and development of innovative treatments in the field.

Conclusion

Steven A Johnson's contributions to the treatment of schizophrenia through his patented methods highlight the importance of innovation in mental health. His work continues to pave the way for more effective therapies and improved patient outcomes.